Skip to main content
. 2021 Mar 5;2021:6642600. doi: 10.1155/2021/6642600

Figure 3.

Figure 3

(a) Intersection of compound Xueshuantong capsule (CXC) targets (blue) and proliferative diabetic retinopathy (PDR) targets (yellow). (b) Intersection of Hexuemingmu tablet (HXMMT) targets (blue) and PDR targets (yellow). (c) Intersection of PDR-CXC targets (blue) and PDR-HXMMT targets (yellow).